US PREMARKET ACTIONS: November 12, 2025
Futures Indices
- Dow Futures: +0.23%
- S&P 500 Futures: +0.35%
- Nasdaq 100 Futures: +0.58%
Market Environment
US markets are rebounding this Wednesday, supported by growing optimism over an imminent deal to end the government shutdown. A vote expected in the House could extend state funding until January 30, or even until the end of September for certain agencies.
Jim Reid (Deutsche Bank) points out:
“Could today finally be the day that we know that the longest government shutdown in history might be coming to an end?”
On Tuesday, the indices closed mixed: the S&P 500 gained +0.21%, despite pressure on Nvidia (-2.96%) and disappointing ADP data. Veterans Day also limited volumes.
Today, several Fed members will speak, including John Williams (NY), Anna Paulson (Philly), Christopher Waller, and Stephen Miran. Their statements will be closely watched for clues on upcoming monetary policy decisions.
Stocks to Watch
** AMD (AMD) +5.9%**
The stock jumps after its Analyst Day. AMD raised its AI outlook, forecasting a $1 trillion data center AI market by 2030. Annual growth expected >35% over 3 to 5 years, thanks to major contracts ($45B) and the rising power of Instinct GPUs.
** Alcon (ALC) +5%**
Q3 results beat expectations, driven by surgical equipment and innovative PanOptix Pro and Tryptyr products. 2025 guidance confirmed with expected revenue between $10.3B and $10.4B.
** Stereotaxis (STXS) -10%**
The company missed Q3 consensus, with a 19% drop in sales. Q4 could exceed $9M but short-term outlook remains tight.
** Biohaven (BHVN) -9.39%**
Sharp drop after announcing a $175M capital raise via a public offering. Short-term dilution impact.
** Eledon Pharmaceuticals (ELDN) -8.45%**
Marked decline after capital increase announcement. The operation weighs on the stock despite clinical prospects.
** CorMedix (CRMD) +9.47%**
Results beat expectations with EPS of $1.26 (vs. $0.63 consensus) and revenue of $104.3M (+$18.2M vs. estimates).
** Creative Media & Community Trust (CMCT) +81.44%**
Spectacular jump after selling its credit division, with no precise details but a strategic repositioning.
** Upexi (UPXI) +6.85%**
Strong Q3 results with EPS of $1.21 and revenue of $9.2M (+$1.87M vs consensus).
** Jumia Technologies (JMIA) +18%**
25% revenue growth in Q3, improved adjusted EBITDA and significant reduction in negative cash flow. Strong operational momentum.
Have a good session everyone
Sylvain Mouilhaud: Stock Coach